The C.A.M. Report
Complementary and Alternative Medicine: Fair, Balanced, and to the Point
  • About this web log

    This blog ran from 2006 to 2016 and was intended as an objective and dispassionate source of information on the latest CAM research. Since my background is in pharmacy and allopathic medicine, I view all CAM as advancing through the development pipeline to eventually become integrated into mainstream medical practice. Some will succeed while others fail. But all are treated fairly here.

  • About the author

    John Russo, Jr., PharmD, is president of The MedCom Resource, Inc. Previously, he was senior vice president of medical communications at, a complementary and alternative medicine website.

  • Common sense considerations

    The material on this weblog is for informational purposes. It is not medical advice or counsel. Be smart, consult your health professional before using CAM.

  • Recent Posts

  • Recent Comments

    Consumer Alert: Vigor-25

    The FDA tells us that Vigor-25, a product marketed as a natural dietary supplement to enhance male sexual performance, should not be purchased or used because it contains sildenafil, the active ingredient in the prescription drug Viagra.

    The FDA is investigating the reported death of a 26-year old man, possibly associated with the use of Vigor-25.


    Sildenafil may interact with prescription drugs known as nitrates, including nitroglycerin, and can dangerously lower blood pressure.

    The bottom line?

    Vigor-25 is distributed by Piston Corp and sold on Internet sites and possibly in some retail stores.

    The FDA advises consumers who have experienced any negative side effects from sexual enhancement products to stop using them. Then, consult a healthcare professional and safely discard the product.

    The FDA urges healthcare professionals and consumers to report adverse events or side effects from Vigor-25 to the FDA’s MedWatch Adverse Event Reporting program.

    11/19/10 18:31 JR

    Leave a Comment

    You must be logged in to post a comment.